Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 12, Pages 3021
Publisher
MDPI AG
Online
2019-06-20
DOI
10.3390/ijms20123021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting mTOR in Acute Lymphoblastic Leukemia
- (2019) Carolina Simioni et al. Cells
- Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALL
- (2019) Chelsea L. Dieck et al. BLOOD
- γ-Secretase and its modulators: Twenty years and beyond
- (2019) Weiming Xia NEUROSCIENCE LETTERS
- The PTEN–PI3K Axis in Cancer
- (2019) Papa et al. Biomolecules
- T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies
- (2018) Eduardo Vadillo et al. BLOOD REVIEWS
- Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors
- (2018) Christopher A.G. Booth et al. CANCER CELL
- Structure and Mechanisms of NT5C2 Mutations Driving Thiopurine Resistance in Relapsed Lymphoblastic Leukemia
- (2018) Chelsea L. Dieck et al. CANCER CELL
- Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas
- (2018) Lan V. Pham et al. CLINICAL CANCER RESEARCH
- Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia
- (2018) Stefano Baldoni et al. INTERNATIONAL JOURNAL OF CANCER
- Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
- (2018) Courtney D DiNardo et al. LANCET ONCOLOGY
- The MCL1-specific inhibitor S63845 acts synergistically with venetoclax/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells
- (2018) Zhaodong Li et al. LEUKEMIA
- Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia
- (2018) Gannie Tzoneva et al. NATURE
- Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-Rα mutations
- (2018) Emilee Senkevitch et al. Oncotarget
- Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
- (2018) Courtney D. DiNardo et al. BLOOD
- PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia
- (2018) Ingrid M. Ariës et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Venetoclax for the treatment of multiple myeloma
- (2018) Iuliana Vaxman et al. Expert Review of Hematology
- Splicing variant profiles and single nucleotide polymorphisms of the glucocorticoid receptor gene in relation to glucocorticoid sensitivity of B-cell precursor acute lymphoblastic leukaemia
- (2017) Meixian Huang et al. HEMATOLOGICAL ONCOLOGY
- Early Response–Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study
- (2017) Jonathan Bond et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic Basis of Acute Lymphoblastic Leukemia
- (2017) Ilaria Iacobucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Leukemia-specific delivery of mutant NOTCH1 targeted therapy
- (2017) Giovanni Roti et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017
- (2017) Patrick A. Brown et al. Journal of the National Comprehensive Cancer Network
- JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias
- (2017) C Delgado-Martin et al. LEUKEMIA
- Rational combination strategies to enhance venetoclax activity and overcome resistance in hematologic malignancies
- (2017) Steven Grant LEUKEMIA & LYMPHOMA
- Pathways and mechanisms of venetoclax resistance
- (2017) Prithviraj Bose et al. LEUKEMIA & LYMPHOMA
- Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemias
- (2016) Brittany Knick Ragon et al. AMERICAN JOURNAL OF HEMATOLOGY
- 4EBP1/c-MYC/PUMA and NF- B/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells
- (2016) S. Yun et al. BLOOD
- Beating the Clock in T-cell Acute Lymphoblastic Leukemia
- (2016) William L. Carroll et al. CLINICAL CANCER RESEARCH
- Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia
- (2016) Yana Pikman et al. CLINICAL CANCER RESEARCH
- Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
- (2016) Stephan Stilgenbauer et al. LANCET ONCOLOGY
- Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signalling
- (2016) C S Tremblay et al. LEUKEMIA
- MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia
- (2016) K Canté-Barrett et al. LEUKEMIA
- Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing Program
- (2016) Min H. Kang et al. PEDIATRIC BLOOD & CANCER
- Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
- (2016) M. Konopleva et al. Cancer Discovery
- The role of p53 in cancer drug resistance and targeted chemotherapy
- (2016) Karin Hientz et al. Oncotarget
- IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study
- (2016) Yunlei Li et al. PLOS MEDICINE
- BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- (2015) S. E. Alford et al. CANCER RESEARCH
- Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
- (2015) M. Andreeff et al. CLINICAL CANCER RESEARCH
- Effective Targeting of the P53-MDM2 Axis in Preclinical Models of Infant MLL-Rearranged Acute Lymphoblastic Leukemia
- (2015) J. Richmond et al. CLINICAL CANCER RESEARCH
- Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235
- (2015) C. P. Hall et al. CLINICAL CANCER RESEARCH
- Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation
- (2015) J. B. Kunz et al. HAEMATOLOGICA
- Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia
- (2015) C. Vicente et al. HAEMATOLOGICA
- Single nucleotide polymorphisms in non-coding region of the glucocorticoid receptor gene and prednisone response in childhood acute lymphoblastic leukemia
- (2015) Lu Xue et al. LEUKEMIA & LYMPHOMA
- Personalized medicine: Time for one-person trials
- (2015) Nicholas J. Schork NATURE
- Genomics in acute lymphoblastic leukaemia: insights and treatment implications
- (2015) Kathryn G. Roberts et al. Nature Reviews Clinical Oncology
- Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia
- (2015) Xiaotu Ma et al. Nature Communications
- PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia
- (2015) André Bortolini Silveira et al. Oncotarget
- Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation
- (2015) J. B. Kunz et al. HAEMATOLOGICA
- Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia
- (2015) C. Vicente et al. HAEMATOLOGICA
- Therapeutic Targeting of c-Myc in T-Cell Acute Lymphoblastic Leukemia (T-ALL)
- (2015) Marie Loosveld et al. Oncotarget
- c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells
- (2014) J. E. Roderick et al. BLOOD
- PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events
- (2014) R. D. Mendes et al. BLOOD
- ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia
- (2014) S. Peirs et al. BLOOD
- Cell and Molecular Determinants of In Vivo Efficacy of the BH3 Mimetic ABT-263 against Pediatric Acute Lymphoblastic Leukemia Xenografts
- (2014) S. Suryani et al. CLINICAL CANCER RESEARCH
- Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential
- (2014) Louise M. Treanor et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
- (2014) Kaushal Parikh et al. Journal of Hematology & Oncology
- An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
- (2014) Birgit Knoechel et al. NATURE GENETICS
- Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents
- (2014) Joel G. Turner et al. SEMINARS IN CANCER BIOLOGY
- Maturation Stage of T-cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199
- (2014) T. N. Chonghaile et al. Cancer Discovery
- New Approaches to Target T-ALL
- (2014) Giovanni Roti et al. Frontiers in Oncology
- KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia
- (2013) Julia Etchin et al. BRITISH JOURNAL OF HAEMATOLOGY
- ABT-199: Taking Dead Aim at BCL-2
- (2013) Matthew S. Davids et al. CANCER CELL
- Complementary Genomic Screens Identify SERCA as a Therapeutic Target in NOTCH1 Mutated Cancer
- (2013) Giovanni Roti et al. CANCER CELL
- Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia
- (2013) Erich Piovan et al. CANCER CELL
- Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer
- (2013) Tom Van Maerken et al. CANCER LETTERS
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability
- (2013) Bryan King et al. CELL
- Selective HDAC1/HDAC2 Inhibitors Induce Neuroblastoma Differentiation
- (2013) Stacey M. Frumm et al. CHEMISTRY & BIOLOGY
- Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia
- (2013) D Koyama et al. LEUKEMIA
- Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia
- (2013) A Lonetti et al. LEUKEMIA
- BCL2-specific inhibitor ABT-199 synergizes strongly with cytarabine against the early immature LOUCY cell line but not more-differentiated T-ALL cell lines
- (2013) N M Anderson et al. LEUKEMIA
- Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
- (2013) Gannie Tzoneva et al. NATURE MEDICINE
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
- (2013) R. Pan et al. Cancer Discovery
- Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
- (2013) T. Pemovska et al. Cancer Discovery
- PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances
- (2012) Lomon So et al. BIOCHEMICAL JOURNAL
- The Requirement for Cyclin D Function in Tumor Maintenance
- (2012) Yoon Jong Choi et al. CANCER CELL
- Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell Leukemia
- (2012) Catherine M. Sawai et al. CANCER CELL
- BH3 profiling – Measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions
- (2012) Victoria Del Gaizo Moore et al. CANCER LETTERS
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
- (2012) Panagis Filippakopoulos et al. CELL
- CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy
- (2012) A. Kathleen McClendon et al. CELL CYCLE
- The bromodomain interaction module
- (2012) Panagis Filippakopoulos et al. FEBS LETTERS
- Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition
- (2012) Jeffry L. Dean et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
- (2012) Jinghui Zhang et al. NATURE
- Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
- (2012) Panagiotis Ntziachristos et al. NATURE MEDICINE
- Nuclear export of proteins and drug resistance in cancer
- (2011) Joel G. Turner et al. BIOCHEMICAL PHARMACOLOGY
- High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation
- (2011) N. Gokbuget et al. BLOOD
- Genetic and proteomic approaches to identify cancer drug targets
- (2011) G Roti et al. BRITISH JOURNAL OF CANCER
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
- (2011) Andrew W. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- Polyethylene Glycol-conjugated L-asparaginase Versus Native L-asparaginase in Combination With Standard Agents for Children With Acute Lymphoblastic Leukemia in Second Bone Marrow Relapse
- (2011) Joanne Kurtzberg et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia
- (2011) Priscila P Zenatti et al. NATURE GENETICS
- Activity of the Novel Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 against T-Cell Acute Lymphoblastic Leukemia
- (2010) F. Chiarini et al. CANCER RESEARCH
- Recognition of nuclear targeting signals by Karyopherin-β proteins
- (2010) Darui Xu et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia
- (2010) Maria Kleppe et al. NATURE GENETICS
- Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
- (2010) Matthew R Janes et al. NATURE MEDICINE
- High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
- (2009) A. Gutierrez et al. BLOOD
- Reversal of P-glycoprotein-Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
- (2009) M. Michaelis et al. CANCER RESEARCH
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
- (2009) Elaine Coustan-Smith et al. LANCET ONCOLOGY
- NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia
- (2009) P J Real et al. LEUKEMIA
- Polymorphisms in glucocorticoid receptor gene and the outcome of childhood acute lymphoblastic leukemia (ALL)
- (2009) Malgorzata Labuda et al. LEUKEMIA RESEARCH
- Mimicking the BH3 domain to kill cancer cells
- (2009) T Ni Chonghaile et al. ONCOGENE
- Proteasome inhibitors induce apoptosis in human lung cancer cells through a positive feedback mechanism and the subsequent Mcl-1 protein cleavage
- (2009) B-Z Yuan et al. ONCOGENE
- Reorganization of the nuclear envelope during open mitosis
- (2008) Ulrike Kutay et al. CURRENT OPINION IN CELL BIOLOGY
- In vitro validation of -secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia
- (2008) K. De Keersmaecker et al. HAEMATOLOGICA
- Acute lymphoblastic leukaemia
- (2008) Ching-Hon Pui et al. LANCET
- MDM2 antagonist nutlin-3 is a potent inducer of apoptosis in pediatric acute lymphoblastic leukemia cells with wild-type p53 and overexpression of MDM2
- (2008) L Gu et al. LEUKEMIA
- Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
- (2008) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia
- (2008) Pedro J Real et al. NATURE MEDICINE
- Class I PI3K in oncogenic cellular transformation
- (2008) L Zhao et al. ONCOGENE
- Treatment of Acute Lymphoblastic Leukemia in Children and Adolescents: Peaks and Pitfalls
- (2008) N. L. Seibel Hematology-American Society of Hematology Education Program
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started